The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
1051 CANDID-B CLOTRIMAZOLE USP 1% W/W, ANHYDROUS BECLOMETASONE DIPROPIONATE B.P 0.025% W/W CREAM TUBE IN THE FOLLOWING FUNGAL INFECTIONS OF THE SKIN, PARTICULARLY WHEN ACCOMPANIED BY ECZEMATOUS FEATURES : TINEA CAPITIS, TINEA CORPORIS, TINEA BARBAE, TINEA CRURIS, TINEA MANUM, TINEA UNGUIUM, TINEA PEDIS, TINEA VERSICOLOR, ERYTHRASMA, CANDIDAL NAPPY RASH, VULVO-VAGINAL CANDIDIASIS, CANDIDA PARONYCHIA NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 2548/05 08-JAN-2024 07-JAN-2027 View
1052 CANDIDERM CLOTRIMAZOLE USP 1%, ANHYDROUS BECLOMETASONE DIPROPIONATE  BP 0.025%, GENTAMICINE SULPHATE BP EQ.TO GENTAMICIN BASE 0.1% CREAM TUBE FOR TOPICAL USE IN A WIDE RANGE OF ECZEMAS AND OTHER INFLAMMATORY AND ALLERGIC DERMATOSES WHERE SECONDARY BACTERIAL AND/OR FUNGAL INFECTION IS PRESENT OR SUSPECTED. NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 2551/05 08-JAN-2024 07-JAN-2027 View
1053 CANDID-V3 CLOTRIMAZOLE USP 200 MG VAGINAL TABLET ALUMINIUM STRIP FOR THE TOPICAL TREATMENT OF VULVOVAGINAL CANDIDIASIS OR CANDIDIAL VULVOVAGINITIS. NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 02 I 2744/06 08-JAN-2024 07-JAN-2027 View
1054 PYRANTEL 125 PYRANTEL 125MG TABLET BLISTERPACK NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR STEP 1: RECEIVE (RENEW) 07 L 0305/98 18-APR-2022 17-APR-2025 View
1055 CEFICAD 1000 CEFEPIME HYDROCHLORIDE USP EQ.TO CEFEPIME 1000 MG (STERILE MIXTURE OF CEFEPIME HCL AND L-ARGININE) POWDER FOR SOLUTION FOR INJECTION VIAL PNEUMONIA (MODERATE TO SEVERE), EMPIRIC THERAPY FOR FIBRILE NEUTROPENIC PATIENTS, UNCOMPLICATED AND COMPLICATED URINARY TRACT INFECTION (INCLUDING PYELONEPHRITIS), UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTION, COMPLICATED INTRA-ABDOMINAL INFECTION. NULL IC Pharma Lao Co., Ltd CADILA PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 03 I 5400/23 17-Mar-2023 16-Mar-2026 View
1056 DOMPERON DOMPERIDONE BP 1 MG/ML ORAL SUSPENSION BOTTLE FOR THE RELIEF OF THE SYMPTOMS OF NAUSEA AND VOMITING NULL IC Pharma Lao Co., Ltd CADILA PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 03 I 5401/23 17-Mar-2023 16-Mar-2026 View
1057 FLUCORT-N SKIN FLUOCINOLONE ACETONIDE 0.025%, NEOMYCIN SULPHATE 0.5% CREAM TUBE ATOPIC ECZEMA, PSORIASIS, SEBORRHOEIC DERMATITIS, CONTACT DERMATITIS, NEURODERMATITIS, LUPUS ERYTHEMATOUS, ERYTHEMA MULTIFORME, PYODERMATITIS, IMPETIGO, OTITIS EXTERNA, ANO-GENITAL AND SENILE PRURITUS NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 06 I 2587/05 08-JAN-2024 07-JAN-2027 View
1058 FORTEC L-ORNITHINE L-ASPARTATE 150 MG TABLET BLISTERPACK HYPERAMMONEMIA IN ACUTE OR CHRONIC LIVER DISEASES( LIVER CIRRHOSIS, FATTY LIVER, HEPATITIS CAUSED BY VIRUS, DRUGS, CHEMICALS, ALCOHOL...), PARTICULARLY IN THE TREATMENT OF CONSCIOUSNESS DISORDER, NEUROLOGICAL COMPLICATION OF PRECOMA, MANIFESTATION OF PRURITUS, ANOREXIA, FATIGUE, ASTHENIA, URTICARIA DUE TO HEPATIC IMPAIRMENT NULL IC Pharma Lao Co., Ltd KOREA UNITED PHARM.INT'L JSC VIETNAM CERTIFICATE RELEASED 06 I 4966/20 21-MAY-2025 20-MAY-2030 View
1059 GATISON EYE DROP GATIFLOXACIN EQ.TO ANHYDROUS GATIFLOXACIN 0.3% W/V OPHTHALMIC SOLUTION VIAL FOR THE TREATMENT OF PATIENTS 1 YEAR OF AGE AND OLDER WITH BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF THE FOLLOWING BACTERIA: STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS EPIDERMIDIS, STREPTOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZAE NULL IC Pharma Lao Co., Ltd ARGON REMEDIES PVT.LTD INDIA CERTIFICATE RELEASED 09 I 5806/24 25-SEP-2024 24-SEP-2029 View
1060 GENSERRA 10 MG SERRATIOPEPTIDASE 10 MG TABLET BLISTERPACK POST-OPREATIVE EDEMA AND HEMATOMA, REMISSION OF SWELLING AFTER SURGICAL STITCHING, RESOLUTION OF TISSUE DRAINAGE, EASE IN POST ANESTHETIC SPUTUM EXPECTORATION NULL IC Pharma Lao Co., Ltd RESCUERS LIFE SCIENCES LTD INDIA CERTIFICATE RELEASED 08 I 4777/19 07-JUN-2023 06-JUN-2026 View